The Lyme Disease Association, Inc. (LDA) formulated a response to FDA to be included in its comment period on its testing Guidance which will affect specialty lab Lyme tests. Groups who wanted to support the position taken by the LDA were able to join in on the letter. Letter was submitted with 73 groups signed on. […]
Sometimes, it is necessary for the Board of Dirctors of the LDA to adopt a formal resolution on issues which are of critical importance to LDA’s mission. Other organizations may follow suit.
The LDA requested Lyme leaders to sign on to a letter against the Amendment in the Nature of a Substitute to HR 4701. Letter with signups was sent 7/7/14 to Energy & Commerce with this note: “Attached please find a letter stating the position of 154 groups from over 35 states across the US opposing […]
The new IDSA guidelines published in October by the Infectious Diseases Society of America (IDSA) are already causing patients to be denied treatment for chronic Lyme disease. The guidelines have recommended against any long term treatments, listing numerous specific antibiotic classes not to be given, listing alternative treatments and even supplements not to be offered […]
VACCINE POSITION PAPER * (There are currently no human vacciens on the market in the US. This applied to the vaccine LymeRix which was withdrawn by the manufacturer citing poor sales). The Association recognizes the need for a safe effective vaccine against Lyme Disease. Several pharmaceutical companies have developed vaccines that are going through the […]